Microneedle Drug Delivery Devices to 2024

microneedle drug delivery devices Microneedle Drug Delivery Devices to 2024  • March 2020  •  MDD292F  •  US $2,850


 

Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration. Microneedle technology has the potential address the growing trend toward self-administration by allowing the precise placement of therapeutic agents at prescribed locations below the skin. To succeed, developers must refine the techniques for large-scale manufacturing and advance the design integration of microneedles into commercially viable drug delivery systems.

Bar_Graph Microneedle Drug Delivery to 2024 Report Brochure (Download PDF)

Blue document Microneedle Drug Delivery Devices to 2024 – Report Order Form (Download PDF)

 

 


Microneedle Drug Delivery Devices to 2024 – What Your Will Learn

  • What approved drug products are currently supplied in microneedle devices and systems, what are the device specifics, and who markets them?
  • Who are the branded microneedle drug delivery device and system suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors that are influencing demand for microneedle drug delivery?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for microneedle drug delivery products?
  • What are the important therapeutic markets for microneedle delivery products and what is their market share now? What will it be in 2024?
  • What are the significant economic, technology, and regulatory factors affecting the market for microneedle drug delivery systems?

 


 Summary of Contents

Executive Summary
Microneedles – Where we are today
Microneedle Demand Drivers
Population Demographics
Chronic Conditions
Patient Self-care
Managed Care Initiatives
Microneedle Arrays & Array Geometries
Microneedle Device Technology
Material Selection
pH-responsive Co-polymers
Fabrication Methods
Microforming
Micromachining
Structured Films
Emerging Fabrication Methods
Additive Manufacturing
InkJet Printing
3D Printing
Electrospun Arrays
Electrodeposition
Magnetization-induced
Self-assembly
Array Architectures
Microneedle Form Factors
Solid Microneedles
Coated Microneedles
Hollow Microneedles
Carbon Nanotubes
Ion Etching
C-MEMS
Electrolyte Sensing
Dissolving Microneedles
Hydrogels
Stretched Needles
Sustained Release Microneedles
Silk Microneedles
Syringe-mounted Microneedles
Specialty Microneedles
Phase Transition
Composite Microneedles
Microprocessor-based Devices
Composite Microneedles
Light-responsive Microneedles
Flexible Arrays
Microneedles & Microfluidics
Wearable Microneedles
Microneedle Device Commercialization Factors
In Vitro Release Testing
Intended Use
Container Closure and Stability
Microneedle Development Initiatives
Non-Profits/NGOs
PATH Center of Excellence for Microarray Patch Technology
Gates Foundation
Government Initiatives
Government Technology Transfer Programs
Europe
Japan
North America
Academic Programs
United Kingdom
South Korea
Netherlands
Japan
Ireland
Sweden
Australia
Italy
Markets and Opportunities
Genetic/DNA/Nucleotide Therapeutics
nRNA
Imunotherapeutics
HIV
Metabolic
Diabetes
Neurology
Migraine
Osteoporosis
Oncology
Vaccines
Prophylactic Vaccines
Vaccine Dose Sparing
Therapeutic Peptides
Market Participant Profiles